Chronic Prescription of Renin-Angiotensin-Aldosterone System Inhibitors and Hospital Outcomes in Patients with Hypertension and COVID-19
The use of ACEi/ARB drugs is not associated with worse outcomes in individuals with COVID-19. The present study demonstrated lower mortality rate associated with the use of these classes of drugs, similar to recent studies.
Authors
- Amanda Oliva Spaziani (ORCID: https://orcid.org/0000-0001-8651-8078)
- Luciana Neves Cosenso‐Martin (ORCID: https://orcid.org/0000-0002-1325-1082)
- Tatiana Palotta Minari (ORCID: https://orcid.org/0000-0003-2008-9287)
- Valquíria da Silva Lopes (ORCID: https://orcid.org/0000-0001-9755-5798)
- Marco Antônio Vieira Silva (ORCID: https://orcid.org/0000-0001-5427-1939)
- Juan Carlos Yugar‐Toledo (ORCID: https://orcid.org/0000-0001-6583-6536)
- Manuela Almeida (ORCID: https://orcid.org/0000-0002-1683-1314)
- Letícia Aparecida Barufi Fernandes (ORCID: https://orcid.org/0000-0003-0547-6326)
- José Fernando Vilela-Martin (ORCID: https://orcid.org/0000-0001-6960-2825)
- Kleber Aparecido de Oliveira (ORCID: https://orcid.org/0000-0002-7747-4680)
- Jessica Rodrigue Roma Uyemura
- H Santos
- Bianca Gasparino Rabelo
Institutions
- Faculdade de Medicina de São José do Rio Preto (BR)
Publication Details
- Journal
- Vascular Health and Risk Management
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/vhrm.s559706
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40